178 related articles for article (PubMed ID: 32578383)
1. Whole exome sequencing of lung adenocarcinoma and lung squamous cell carcinoma in one individual: A case report.
Bai Y; Xu Y; Wang X; Liu Y; Sun C; Guo Y; Cai Y; Shao G; Yang Z; Qiu S; Ma K
Thorac Cancer; 2020 Aug; 11(8):2361-2364. PubMed ID: 32578383
[TBL] [Abstract][Full Text] [Related]
2. Genomic scoring to determine clinical benefit of immunotherapy by targeted sequencing.
Kim HS; Cha H; Kim J; Park WY; Choi YL; Sun JM; Ahn JS; Ahn MJ; Park K; Lee SH
Eur J Cancer; 2019 Oct; 120():65-74. PubMed ID: 31493723
[TBL] [Abstract][Full Text] [Related]
3. Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma: A case report.
Vanni I; Coco S; Bonfiglio S; Cittaro D; Genova C; Biello F; Mora M; Rossella V; Dal Bello MG; Truini A; Banelli B; Lazarevic D; Alama A; Rijavec E; Barletta G; Grossi F
Medicine (Baltimore); 2016 Nov; 95(48):e5447. PubMed ID: 27902597
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of atypical adenomatous hyperplasia, minimally invasive adenocarcinoma and invasive adenocarcinoma: Gene mutation analysis.
Song J; Xu Y; Yang Z; Liu Y; Zhang P; Wang X; Sun C; Guo Y; Qiu S; Shao G; Ma K
Thorac Cancer; 2021 Mar; 12(5):693-698. PubMed ID: 33442956
[TBL] [Abstract][Full Text] [Related]
5. Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers.
Hu C; Zhao L; Liu W; Fan S; Liu J; Liu Y; Liu X; Shu L; Liu X; Liu P; Deng C; Qiu Z; Chen C; Jiang Y; Liang Q; Yang L; Shao Y; He Q; Yu D; Zeng Y; Li Y; Pan Y; Zhang S; Shi S; Peng Y; Wu F
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887263
[TBL] [Abstract][Full Text] [Related]
6. A multidisciplinary approach for the differential diagnosis between multiple primary lung adenocarcinomas and intrapulmonary metastases.
Belardinilli F; Pernazza A; Mahdavian Y; Cerbelli B; Bassi M; Gradilone A; Coppa A; Pignataro MG; Anile M; Venuta F; Della Rocca C; Giannini G; d'Amati G
Pathol Res Pract; 2021 Apr; 220():153387. PubMed ID: 33647865
[TBL] [Abstract][Full Text] [Related]
7. Genetic and immune characteristics of multiple primary lung cancers and lung metastases.
Yang R; Li P; Wang D; Wang L; Yin J; Yu B; Li M; Wang S; Wang Y
Thorac Cancer; 2021 Oct; 12(19):2544-2550. PubMed ID: 34510768
[TBL] [Abstract][Full Text] [Related]
8. Whole-Exome Sequencing Could Distinguish Primary Pulmonary Squamous Cell Carcinoma From Lung Metastases in Individuals With Cervical Squamous Cell Carcinoma.
Li L; Song Q; Cao D; Jiao Y; Yuan G; Song Y
Pathol Oncol Res; 2022; 28():1610325. PubMed ID: 35645619
[No Abstract] [Full Text] [Related]
9. Epigenetic alterations are associated with tumor mutation burden in non-small cell lung cancer.
Cai L; Bai H; Duan J; Wang Z; Gao S; Wang D; Wang S; Jiang J; Han J; Tian Y; Zhang X; Ye H; Li M; Huang B; He J; Wang J
J Immunother Cancer; 2019 Jul; 7(1):198. PubMed ID: 31349879
[TBL] [Abstract][Full Text] [Related]
10. Morphological, immune and genetic features in biopsy sample associated with the efficacy of pembrolizumab in patients with non-squamous non-small cell lung cancer.
Sakai T; Udagawa H; Matsumoto S; Yoh K; Nosaki K; Ikeda T; Zenke Y; Kirita K; Niho S; Akimoto T; Goto K; Ishii G
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1227-1237. PubMed ID: 32997195
[TBL] [Abstract][Full Text] [Related]
11. Genomic profiles and transcriptomic microenvironments in 2 patients with synchronous lung adenocarcinoma and lung squamous cell carcinoma: a case report.
Wu L; Kang P; Tao S; Zhao Z; Chen L; Xiao Y; Tan Q
BMC Med Genomics; 2020 Jan; 13(1):15. PubMed ID: 32005243
[TBL] [Abstract][Full Text] [Related]
12. Integrating Imaging, Histologic, and Genetic Features to Predict Tumor Mutation Burden of Non-Small-Cell Lung Cancer.
Zhang N; Wu J; Yu J; Zhu H; Yang M; Li R
Clin Lung Cancer; 2020 May; 21(3):e151-e163. PubMed ID: 31734072
[TBL] [Abstract][Full Text] [Related]
13. Paired analysis of tumor mutation burden calculated by targeted deep sequencing panel and whole exome sequencing in non-small cell lung cancer.
Park S; Lee C; Ku BM; Kim M; Park WY; Kim NKD; Ahn MJ
BMB Rep; 2021 Jul; 54(7):386-391. PubMed ID: 34154699
[TBL] [Abstract][Full Text] [Related]
14. Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non-small cell lung cancer patients.
Ding Y; Zhang L; Guo L; Wu C; Zhou J; Zhou Y; Ma J; Li X; Ji P; Wang M; Zhu W; Shi C; Li S; Wu W; Zhu W; Xiao D; Fu C; He Q; Sun R; Mao X; Lizaso A; Li B; Han-Zhang H; Zhang Z
Thorac Cancer; 2020 Jan; 11(1):103-112. PubMed ID: 31692283
[TBL] [Abstract][Full Text] [Related]
15. The Landscape of Actionable Molecular Alterations in Immunomarker-Defined Large-Cell Carcinoma of the Lung.
Chan AW; Chau SL; Tong JH; Chow C; Kwan JSH; Chung LY; Lung RW; Tong CY; Tin EK; Law PP; Law WT; Ng CSH; Wan IYP; Mok TSK; To KF
J Thorac Oncol; 2019 Jul; 14(7):1213-1222. PubMed ID: 30978501
[TBL] [Abstract][Full Text] [Related]
16. Identification of second primary tumors from lung metastases in patients with esophageal squamous cell carcinoma using whole-exome sequencing.
Xue L; Li W; Fan X; Zhao Z; Zhou W; Feng Z; Liu L; Lin H; Li L; Xue X; Huang X; Huang P; Guo J; Du P; Lu N; Li L; Zhan Q; Song Y
Theranostics; 2020; 10(23):10606-10618. PubMed ID: 32929369
[TBL] [Abstract][Full Text] [Related]
17. Metachronous primary lung adenocarcinomas harboring distinct KRAS mutations.
Hu Y; Ren S; Chen C; Liang Q; Yu F; Liu W
Thorac Cancer; 2020 Jul; 11(7):2018-2022. PubMed ID: 32415761
[TBL] [Abstract][Full Text] [Related]
18. Assessment of associations between clinical and immune microenvironmental factors and tumor mutation burden in resected nonsmall cell lung cancer by applying machine learning to whole-slide images.
Ono A; Terada Y; Kawata T; Serizawa M; Isaka M; Kawabata T; Imai T; Mori K; Muramatsu K; Hayashi I; Kenmotsu H; Ohshima K; Urakami K; Nagashima T; Kusuhara M; Akiyama Y; Sugino T; Ohde Y; Yamaguchi K; Takahashi T
Cancer Med; 2020 Jul; 9(13):4864-4875. PubMed ID: 32400056
[TBL] [Abstract][Full Text] [Related]
19. Tumor Mutational Burden by Whole-Genome Sequencing in Resected NSCLC of Never Smokers.
Ruel LJ; Li Z; Gaudreault N; Henry C; Saavedra Armero V; Boudreau DK; Zhang T; Landi MT; Labbé C; Couture C; Desmeules P; Joubert P; Bossé Y
Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2219-2227. PubMed ID: 36126278
[TBL] [Abstract][Full Text] [Related]
20. Use of Oncogenic Driver Mutations in Staging of Multiple Primary Lung Carcinomas: A Single-Center Experience.
Asmar R; Sonett JR; Singh G; Mansukhani MM; Borczuk AC
J Thorac Oncol; 2017 Oct; 12(10):1524-1535. PubMed ID: 28647671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
